Navigating the Medical Device Commercialization Maze
“Healthcare revolves around patients and caring for those patients. The Hippocratic oath of 'first do no harm' is so prominent in medicine because patient lives are at stake.”
— Christopher Benassi, VP, Product Management & Innovation, Connected Care Group, Baxter International
With commercialization timelines growing longer and market competition intensifying, MedTech leaders are rethinking how they bring innovation to market.
Thanks to the insights shared by senior executives from Baxter, BD, and Johnson & Johnson MedTech during our recent webinar, this brand-new report explores how organizations are balancing innovation, regulation, and patient-centricity to achieve commercial success.
Download your free report here to benchmark your commercialization strategy and take the right approach for your business >>>
This report explores how cross-functional planning, agile development, and operational excellence are helping companies differentiate and sustain momentum in increasingly commoditized markets.
Join the hundreds of professionals already leveraging these insights to refine their go-to-market strategies and deliver better patient outcomes.
Download your free report here to benchmark your commercialization strategy and take the right approach for your business >>>
We hope this report and its findings prove useful to your business and role.
Kind regards,
Gain exclusive access to the report now!
By submitting this form, you acknowledge the Thomson Reuters group of companies will process your personal information as described in our Privacy Statement
which explains how we collect, use, store, and disclose your personal information, the consequences if you do
not provide this information, and the way in which you
can access and correct your personal information or submit a complaint.
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.